Ivan Zimmermann

15PUBLICATIONS
97CO-AUTHORS
Pharmaceutical delivery technologiesCancer geneticsPharmacogenomicsNanomedicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Mar 18, 2026
[Expansion of the use of technologies to reduce cases of malaria due to Plasmodium vivax in the Brazilian Amazon: a budget impact analysis].

Márcia Gisele Santos da Costa, Ivan Zimmermann, Ana Carolina Carioca da Costa

|Jan 30, 2026
Cost-Effectiveness of the Oncotype DX Breast Recurrence Score Test in the Brazilian Private Health Care Sector.

Ivan Zimmermann, Carlos Alberto da Silva Magliano, Leandro Jonata de Carvalho Oliveira

|Jan 30, 2026
Relational database for drug utilization studies (DUS) in Brazil: analysis and integration of outpatient data.

Roberto Eduardo Schneiders, Andréia Turmina Fontanella, Ivan Ricardo Zimmermann

|Dec 10, 2025
Nivolumab and pembrolizumab in the treatment of metastatic melanoma: a retrospective budget impact analysis from the perspective of the Brazilian National Health System, Brazil, 2019-2022.

Ricardo Ribeiro Alves Fernandes, Keitty Regina Cordeiro de Andrade, Ivan Ricardo Zimmermann

|Oct 22, 2025
Budget Impact of the Oncotype DX Test in Early-Stage Breast Cancer for the Brazilian Private Health Care System.

Carlos Alberto da Silva Magliano, Ivan R Zimmermann, Leandro Jonata de Carvalho Oliveira

|Mar 27, 2024
Isoniazid use, effectiveness, and safety for treatment of latent tuberculosis infection: a systematic review.

Bárbara Manuella Cardoso Sodré-Alves, Melina Mafra Toledo, Ivan Ricardo Zimmermann

Pageof 3

Frequent Collaborators

3 joint publications

Carlos Magliano

2 joint publications

Carlos Henrique Dos Anjos

2 joint publications

Virginia Areal

2 joint publications

Max S Mano